vs

Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and WESTAMERICA BANCORPORATION (WABC). Click either name above to swap in a different company.

WESTAMERICA BANCORPORATION is the larger business by last-quarter revenue ($63.3M vs $49.9M, roughly 1.3× MARAVAI LIFESCIENCES HOLDINGS, INC.). WESTAMERICA BANCORPORATION runs the higher net margin — 43.9% vs -71.6%, a 115.5% gap on every dollar of revenue. On growth, WESTAMERICA BANCORPORATION posted the faster year-over-year revenue change (-9.0% vs -11.8%). WESTAMERICA BANCORPORATION produced more free cash flow last quarter ($119.7M vs $-24.9M). Over the past eight quarters, WESTAMERICA BANCORPORATION's revenue compounded faster (-8.6% CAGR vs -11.9%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

Westamerica Bancorporation is a regional bank holding company headquartered in California, U.S. It operates via its wholly owned banking subsidiary to provide full-spectrum retail and commercial banking services, including deposit products, business and consumer loans, wealth management, and payment services, primarily serving individual consumers, SMEs and local institutional clients in northern and central California.

MRVI vs WABC — Head-to-Head

Bigger by revenue
WABC
WABC
1.3× larger
WABC
$63.3M
$49.9M
MRVI
Growing faster (revenue YoY)
WABC
WABC
+2.8% gap
WABC
-9.0%
-11.8%
MRVI
Higher net margin
WABC
WABC
115.5% more per $
WABC
43.9%
-71.6%
MRVI
More free cash flow
WABC
WABC
$144.5M more FCF
WABC
$119.7M
$-24.9M
MRVI
Faster 2-yr revenue CAGR
WABC
WABC
Annualised
WABC
-8.6%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MRVI
MRVI
WABC
WABC
Revenue
$49.9M
$63.3M
Net Profit
$-35.7M
$27.8M
Gross Margin
25.8%
Operating Margin
-117.9%
59.8%
Net Margin
-71.6%
43.9%
Revenue YoY
-11.8%
-9.0%
Net Profit YoY
-37.7%
-12.3%
EPS (diluted)
$-0.24
$1.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRVI
MRVI
WABC
WABC
Q4 25
$49.9M
$63.3M
Q3 25
$41.6M
$63.7M
Q2 25
$47.4M
$64.6M
Q1 25
$46.9M
$66.4M
Q4 24
$56.6M
$69.6M
Q3 24
$69.0M
$74.1M
Q2 24
$69.4M
$74.3M
Q1 24
$64.2M
$75.8M
Net Profit
MRVI
MRVI
WABC
WABC
Q4 25
$-35.7M
$27.8M
Q3 25
$-25.6M
$28.3M
Q2 25
$-39.6M
$29.1M
Q1 25
$-29.9M
$31.0M
Q4 24
$-25.9M
$31.7M
Q3 24
$-97.1M
$35.1M
Q2 24
$-9.8M
$35.5M
Q1 24
$-12.1M
$36.4M
Gross Margin
MRVI
MRVI
WABC
WABC
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
46.7%
Q2 24
44.4%
Q1 24
40.3%
Operating Margin
MRVI
MRVI
WABC
WABC
Q4 25
-117.9%
59.8%
Q3 25
-98.6%
59.5%
Q2 25
-139.8%
60.5%
Q1 25
-104.9%
63.0%
Q4 24
-66.7%
62.8%
Q3 24
-239.9%
64.5%
Q2 24
-19.4%
64.8%
Q1 24
-29.4%
65.2%
Net Margin
MRVI
MRVI
WABC
WABC
Q4 25
-71.6%
43.9%
Q3 25
-61.4%
44.3%
Q2 25
-83.5%
45.0%
Q1 25
-63.9%
46.7%
Q4 24
-45.8%
45.6%
Q3 24
-140.6%
47.3%
Q2 24
-14.1%
47.8%
Q1 24
-18.8%
48.0%
EPS (diluted)
MRVI
MRVI
WABC
WABC
Q4 25
$-0.24
$1.12
Q3 25
$-0.18
$1.12
Q2 25
$-0.27
$1.12
Q1 25
$-0.21
$1.16
Q4 24
$-0.21
$1.19
Q3 24
$-0.68
$1.31
Q2 24
$-0.07
$1.33
Q1 24
$-0.09
$1.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRVI
MRVI
WABC
WABC
Cash + ST InvestmentsLiquidity on hand
$216.9M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$212.4M
$933.5M
Total Assets
$770.6M
$6.0B
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRVI
MRVI
WABC
WABC
Q4 25
$216.9M
Q3 25
$243.6M
Q2 25
$269.9M
Q1 25
$285.1M
Q4 24
$322.4M
Q3 24
$578.2M
Q2 24
$573.2M
Q1 24
$561.7M
Total Debt
MRVI
MRVI
WABC
WABC
Q4 25
$291.8M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
Q3 24
$521.7M
Q2 24
$522.5M
Q1 24
$523.3M
Stockholders' Equity
MRVI
MRVI
WABC
WABC
Q4 25
$212.4M
$933.5M
Q3 25
$245.4M
$931.6M
Q2 25
$265.9M
$921.8M
Q1 25
$300.6M
$923.1M
Q4 24
$325.3M
$890.0M
Q3 24
$344.9M
$909.0M
Q2 24
$434.7M
$815.6M
Q1 24
$410.7M
$791.7M
Total Assets
MRVI
MRVI
WABC
WABC
Q4 25
$770.6M
$6.0B
Q3 25
$849.2M
$5.9B
Q2 25
$897.0M
$5.8B
Q1 25
$959.8M
$6.0B
Q4 24
$1.0B
$6.1B
Q3 24
$1.3B
$6.2B
Q2 24
$1.4B
$6.3B
Q1 24
$1.4B
$6.5B
Debt / Equity
MRVI
MRVI
WABC
WABC
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
Q3 24
1.51×
Q2 24
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRVI
MRVI
WABC
WABC
Operating Cash FlowLast quarter
$-22.8M
$121.9M
Free Cash FlowOCF − Capex
$-24.9M
$119.7M
FCF MarginFCF / Revenue
-49.9%
189.0%
Capex IntensityCapex / Revenue
4.2%
3.5%
Cash ConversionOCF / Net Profit
4.38×
TTM Free Cash FlowTrailing 4 quarters
$-70.7M
$213.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRVI
MRVI
WABC
WABC
Q4 25
$-22.8M
$121.9M
Q3 25
$-15.2M
$29.4M
Q2 25
$-10.3M
$23.5M
Q1 25
$-9.4M
$42.4M
Q4 24
$-14.6M
$141.6M
Q3 24
$13.1M
$40.6M
Q2 24
$17.4M
$19.0M
Q1 24
$-8.5M
$52.2M
Free Cash Flow
MRVI
MRVI
WABC
WABC
Q4 25
$-24.9M
$119.7M
Q3 25
$-18.1M
$28.7M
Q2 25
$-13.1M
$22.8M
Q1 25
$-14.6M
$42.2M
Q4 24
$-20.5M
$139.8M
Q3 24
$4.5M
$40.1M
Q2 24
$7.9M
$18.6M
Q1 24
$-14.1M
$52.1M
FCF Margin
MRVI
MRVI
WABC
WABC
Q4 25
-49.9%
189.0%
Q3 25
-43.4%
45.1%
Q2 25
-27.7%
35.3%
Q1 25
-31.2%
63.5%
Q4 24
-36.2%
201.0%
Q3 24
6.6%
54.1%
Q2 24
11.4%
25.0%
Q1 24
-22.0%
68.7%
Capex Intensity
MRVI
MRVI
WABC
WABC
Q4 25
4.2%
3.5%
Q3 25
7.0%
1.1%
Q2 25
6.1%
1.1%
Q1 25
11.2%
0.3%
Q4 24
10.3%
2.5%
Q3 24
12.4%
0.7%
Q2 24
13.8%
0.6%
Q1 24
8.8%
0.2%
Cash Conversion
MRVI
MRVI
WABC
WABC
Q4 25
4.38×
Q3 25
1.04×
Q2 25
0.81×
Q1 25
1.37×
Q4 24
4.47×
Q3 24
1.16×
Q2 24
0.54×
Q1 24
1.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

WABC
WABC

Segment breakdown not available.

Related Comparisons